Pune, Maharashtra-based biotech firm Mylab Solutions announced an exclusive strategic partnership with AstraGene LLC, UAE’s first Molecular Diagnostics Manufacturing company, for developing automated molecular diagnostics for the UAE and Kuwait markets. Under the agreement, Mylab and AstraGene will co-develop molecular diagnostic solutions, including reagents, kits and fully-automated devices. This partnership...
Thermo Fisher, India’s Mylab Collaborate on Test Kits
Waltham, MA -based Thermo Fisher Scientific, which has facilities in Bangalore, partnered with Pune-based startup Mylab Discovery Solutions to source RT- PCR kits for infectious diseases. Some of the kits developed by Mylab have already received licensing rights from India's regulatory body, the Central Drugs Standard Control Organization. Mylab’s portfolio...
Germany’s Prejex Inc., Partners India’s Polybond for Needle-less Injections
Prejex Inc., a spin-off of Germany-based Prejex GMBH, entered into an agreement with Pune India-based Polybond, of the Rathi Group, to manufacture needle-less injections. This partnership has enabled the shifting of the manufacturing capabilities of the German company from Berlin to Pune. The Prejex-Polybond factory will make needle-less injections for...
Device Monitors Respiratory Disorders Remotely
About five years ago, a group of researchers at ETH Zurich, a public research university in Zurich, Switzerland were working on solving problems related to the complications of a sleep study. Soumya Sundar Dash was invited to the sleep lab to share his expert opinion on the study being conducted....
New Medtech Device Measures Respiratory Disorders Remotely
About five years ago, a group of researchers at ETH Zurich, a public research university in Zurich, Switzerland, were working on solving problems related to the complications of a sleep study. Soumya Sundar Dash was invited to the sleep lab to share his expert opinion on the study being conducted....
India’s Serum Institute Invests in Oxford Biomedica Plc
Pune, Maharshtra-based Serum Institute of India (SII) invested over $68 million in UK-based Oxford Biomedica plc, a gene and cell therapy company specializing in the development of gene-based medicines. Serum Life Sciences Ltd, a unit of SII, will pick up a 3.9% stake in Oxford Biomedica as part of the...